help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Panerai, A. E.
Right arrow Articles by Genazzani, A. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Panerai, A. E.
Right arrow Articles by Genazzani, A. R.

Endocrinology, Vol 117, 1096-1099, Copyright © 1985 by Endocrine Society


ARTICLES

Mainly mu-opiate receptors are involved in luteinizing hormone and prolactin secretion

AE Panerai, F Petraglia, P Sacerdote and AR Genazzani

We evaluated plasma PRL and LH concentrations in the rat after the administration of drugs that exert a specificity directed mainly, although not absolutely, toward the mu-, delta-, or kappa-opiate receptors, in order to investigate the role of different receptors and thus the respective endogenous ligands in the modulation of the release of these anterior pituitary hormones. LH concentrations were evaluated in prepuberal female rats, in adult male rats, and in ovariectomized, estradiol benzoate-treated rats. PRL concentrations were evaluated in suckling rats, in ovariectomized, estradiol benzoate-treated rats, and in ether-stressed rats. The delta-antagonist ICI 154129 never affected PRL or LH concentrations, whereas both the mu- and kappa-antagonists, naloxone and MR 1452, respectively, seemed to be effective. However, when graded doses of the two classes of antagonists were tested, the mu- antagonist appeared to be effective on both hormones at doses that were one tenth of those of the kappa-antagonist. In conclusion, the mu- receptor seems to be the most profoundly involved in the regulation of PRL and LH secretion.


This article has been cited by other articles:


Home page
EndocrinologyHome page
R. L. Goodman, L. M. Coolen, G. M. Anderson, S. L. Hardy, M. Valent, J. M. Connors, M. E. Fitzgerald, and M. N. Lehman
Evidence That Dynorphin Plays a Major Role in Mediating Progesterone Negative Feedback on Gonadotropin-Releasing Hormone Neurons in Sheep
Endocrinology, June 1, 2004; 145(6): 2959 - 2967.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
J. Hangaard, M. Andersen, E. Grodum, O. Koldkjær, and C. Hagen
The Effects of Endogenous Opioids and Cortisol on Thyrotropin and Prolactin Secretion in Patients with Addison's Disease
J. Clin. Endocrinol. Metab., May 1, 1999; 84(5): 1595 - 1601.
[Abstract] [Full Text]


Home page
EndocrinologyHome page
G. K. Bhat, V. B. Mahesh, L. Ping, L. Chorich, V. T. Wiedmeier, and D. W. Brann
Opioid-Glutamate-Nitric Oxide Connection in the Regulation of Luteinizing Hormone Secretion in the Rat
Endocrinology, March 1, 1998; 139(3): 955 - 960.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
M. I. Sannella and S. L. Petersen
Dual Label in Situ Hybridization Studies Provide Evidence that Luteinizing Hormone-Releasing Hormone Neurons Do Not Synthesize Messenger Ribonucleic Acid for {micro}, {kappa}, or {delta} Opiate Receptors
Endocrinology, April 1, 1997; 138(4): 1667 - 1672.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1985 by The Endocrine Society